Mary L. (Nora)
Disis
M.D.
(206) 543-8557
Cancer Vaccine Institute
University of Washington
850 Republican Street
Brotman Bldg., Room 221
Box 358050
Seattle, WA 98109
Education, Training, Board Certifications
- M.D., University of Nebraska
- M.S., Immunology, University of Nebraska
- Internal Medicine, American Board of Internal Medicine
- Fellowship in Oncology, UW
Clinical Expertise
- Breast cancer
- Ovarian cancer
- Tumor immunotherapy
Affiliations
- University of Washington
- Institute of Translational Health Sciences, UW
- Fred Hutchinson Cancer Center - Faculty & Lab
Publications
Research and/or clinical interests
Dr. Mary “Nora” Disis is an expert in the immunology and immunotherapy of breast and ovarian cancers with an emphasis on cancer vaccines. She is dedicated to translating lab discoveries into the clinic for patients and holds several patents for targeted cancer therapies and diagnostics. Dr. Disis’ research interest lies in the discovery of new molecular targets in solid tumors for the development of vaccine and cellular therapy for the treatment and prevention of common malignancies. In addition to her research and clinical work, Dr. Disis is a member of Alpha Omega Alpha and the American Society of Clinical Investigation. She is the Editor in Chief for JAMA Oncology, and is a member of several committees and task forces for both the American Society of Clinical Oncology (ASCO) and the American Association for Cancer Research (AACR).